The current analysis examined the effects of hemoadsorption in patients with severe rhabdomyolysis (e.g. myoglobin > 10,000 μg/L) by comparing changes in myoglobin and creatinine levels over time and the associated clinical impact. This evidence concerns the gene MB and rhabdomyolysis.